Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy : in vitro and in vivo evaluation and direct comparison to poly[ N -(2-hydroxypropyl)methacrylamide] analogues
- Author
- Ondrej Sedlacek (UGent) , Bryn Monnery (UGent) , Jana Mattova, Jan Kucka, Jiri Panek, Olga Janouskova, Anita Hocherl, Bart Verbraeken (UGent) , Maarten Vergaelen (UGent) , Marie Zadinova, Richard Hoogenboom (UGent) and Martin Hruby
- Organization
- Keywords
- Poly(2-oxazoline), Drug delivery, Doxorubicin, Nanomedicine, Hydrazone bond, PH-CONTROLLED ACTIVATION, DRUG-DELIVERY SYSTEMS, HPMA COPOLYMERS, PHYSICOCHEMICAL CHARACTERIZATION, POLY(2-OXAZOLINE)S, CYTOTOXICITY, RELEASE, NANOMEDICINES, THERAPEUTICS, ALTERNATIVES
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 3.41 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8544729
- MLA
- Sedlacek, Ondrej, et al. “Poly(2-Ethyl-2-Oxazoline) Conjugates with Doxorubicin for Cancer Therapy : In Vitro and in Vivo Evaluation and Direct Comparison to Poly[ N -(2-Hydroxypropyl)Methacrylamide] Analogues.” BIOMATERIALS, vol. 146, 2017, pp. 1–12, doi:10.1016/j.biomaterials.2017.09.003.
- APA
- Sedlacek, O., Monnery, B., Mattova, J., Kucka, J., Panek, J., Janouskova, O., … Hruby, M. (2017). Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy : in vitro and in vivo evaluation and direct comparison to poly[ N -(2-hydroxypropyl)methacrylamide] analogues. BIOMATERIALS, 146, 1–12. https://doi.org/10.1016/j.biomaterials.2017.09.003
- Chicago author-date
- Sedlacek, Ondrej, Bryn Monnery, Jana Mattova, Jan Kucka, Jiri Panek, Olga Janouskova, Anita Hocherl, et al. 2017. “Poly(2-Ethyl-2-Oxazoline) Conjugates with Doxorubicin for Cancer Therapy : In Vitro and in Vivo Evaluation and Direct Comparison to Poly[ N -(2-Hydroxypropyl)Methacrylamide] Analogues.” BIOMATERIALS 146: 1–12. https://doi.org/10.1016/j.biomaterials.2017.09.003.
- Chicago author-date (all authors)
- Sedlacek, Ondrej, Bryn Monnery, Jana Mattova, Jan Kucka, Jiri Panek, Olga Janouskova, Anita Hocherl, Bart Verbraeken, Maarten Vergaelen, Marie Zadinova, Richard Hoogenboom, and Martin Hruby. 2017. “Poly(2-Ethyl-2-Oxazoline) Conjugates with Doxorubicin for Cancer Therapy : In Vitro and in Vivo Evaluation and Direct Comparison to Poly[ N -(2-Hydroxypropyl)Methacrylamide] Analogues.” BIOMATERIALS 146: 1–12. doi:10.1016/j.biomaterials.2017.09.003.
- Vancouver
- 1.Sedlacek O, Monnery B, Mattova J, Kucka J, Panek J, Janouskova O, et al. Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy : in vitro and in vivo evaluation and direct comparison to poly[ N -(2-hydroxypropyl)methacrylamide] analogues. BIOMATERIALS. 2017;146:1–12.
- IEEE
- [1]O. Sedlacek et al., “Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy : in vitro and in vivo evaluation and direct comparison to poly[ N -(2-hydroxypropyl)methacrylamide] analogues,” BIOMATERIALS, vol. 146, pp. 1–12, 2017.
@article{8544729,
author = {{Sedlacek, Ondrej and Monnery, Bryn and Mattova, Jana and Kucka, Jan and Panek, Jiri and Janouskova, Olga and Hocherl, Anita and Verbraeken, Bart and Vergaelen, Maarten and Zadinova, Marie and Hoogenboom, Richard and Hruby, Martin}},
issn = {{0142-9612}},
journal = {{BIOMATERIALS}},
keywords = {{Poly(2-oxazoline),Drug delivery,Doxorubicin,Nanomedicine,Hydrazone bond,PH-CONTROLLED ACTIVATION,DRUG-DELIVERY SYSTEMS,HPMA COPOLYMERS,PHYSICOCHEMICAL CHARACTERIZATION,POLY(2-OXAZOLINE)S,CYTOTOXICITY,RELEASE,NANOMEDICINES,THERAPEUTICS,ALTERNATIVES}},
language = {{eng}},
pages = {{1--12}},
title = {{Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy : in vitro and in vivo evaluation and direct comparison to poly[ N -(2-hydroxypropyl)methacrylamide] analogues}},
url = {{http://doi.org/10.1016/j.biomaterials.2017.09.003}},
volume = {{146}},
year = {{2017}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: